Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cohort Study of Patients With Hepatocellular Carcinoma and Circulating Tumor DNA Monitoring of Chemoembolization

NCT05390112 is registered in ClinicalTrials.gov with University Hospital, Rouen as lead sponsor.

NCT NCT05390112
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05390112 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cohort Study of Patients With Hepatocellular Carcinoma and Circulating Tumor DNA Monitoring of Chemoembolization
Lead sponsor
University Hospital, Rouen
Phase
Observational
Overall status
Unknown status
Start date
May 20, 2021
Completion date
December 31, 2024
Enrollment
167 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

circulating tumor dna, hepatocellular carcinoma non-resectable, transarterial chemoembolization